Aevis Victoria SA (SWX:AEVS)
Switzerland · Delayed Price · Currency is CHF 13.75
-0.15 (-1.08%)
At close: Mar 12, 2026
Aevis Victoria Market Cap
Aevis Victoria has a market cap or net worth of 1.17 billion as of March 12, 2026. Its market cap has increased by 0.36% in one year.
Market Cap
1.17B
Enterprise Value
2.16B
Revenue
955.96M
Ranking
n/a
PE Ratio
562.22
Stock Price
13.75
Market Cap Chart
Since July 5, 1999, Aevis Victoria's market cap has increased from 2.40M to 1.17B, an increase of 48,789.97%. That is a compound annual growth rate of 26.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 1.17B | 4.12% |
| Dec 30, 2025 | 1.13B | -10.38% |
| Dec 30, 2024 | 1.26B | -11.76% |
| Dec 29, 2023 | 1.42B | -3.64% |
| Dec 30, 2022 | 1.48B | 20.89% |
| Dec 30, 2021 | 1.22B | 17.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 265.72B |
| Novartis AG | 239.09B |
| Galderma Group AG | 36.57B |
| Lonza Group AG | 35.02B |
| Tecan Group AG | 1.60B |
| Cosmo Pharmaceuticals | 1.53B |
| SKAN Group AG | 1.10B |
| Kuros Biosciences AG | 1.04B |